| Gestational diabetes and risk of cardiovascular disease up to 25 years after pregnancy: a retrospective cohort study S McKenzie-Sampson, G Paradis, J Healy-Profitós, F St-Pierre, N Auger Acta diabetologica 55, 315-322, 2018 | 129 | 2018 |
| The Matilda effect: underrecognition of women in hematology and oncology awards SR Patel, F St. Pierre, AI Velazquez, S Ananth, U Durani, ... The oncologist 26 (9), 779-786, 2021 | 44 | 2021 |
| Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma F St‐Pierre, SM Broski, BR LaPlant, K Ristow, MJ Maurer, WR Macon, ... American journal of hematology 94 (7), 786-793, 2019 | 24 | 2019 |
| Harnessing natural killer cells in cancer immunotherapy: a review of mechanisms and novel therapies F St-Pierre, S Bhatia, S Chandra Cancers 13 (8), 1988, 2021 | 20 | 2021 |
| Use of BTK inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): a practical guidance F St-Pierre, S Ma Blood and Lymphatic Cancer: Targets and Therapy, 81-98, 2022 | 17 | 2022 |
| CAR T-cell therapy for relapsed/refractory non-Hodgkin's lymphoma: a comprehensive review F St-Pierre, LI Gordon Clin Adv Hematol Oncol 20 (5), 309-318, 2022 | 12 | 2022 |
| Fluorodeoxyglucose‐positron emission tomography predicts bone marrow involvement in the staging of follicular lymphoma F St‐Pierre, SM Broski, BR LaPlant, MJ Maurer, K Ristow, ... The Oncologist 25 (8), 689-695, 2020 | 11 | 2020 |
| R-CHOP versus R-Bendamustine with or without rituximab maintenance in newly diagnosed follicular lymphoma patients with high SUV at baseline PET P Mondello, P Strati, RW Merryman, E Joffe, M Ruella, V Seshan, ... Blood 136, 39-40, 2020 | 9 | 2020 |
| Lisocabtagene maraleucel in the treatment of relapsed/refractory large B-cell lymphoma F St-Pierre, LI Gordon Future Oncology 19 (1), 19-28, 2023 | 6 | 2023 |
| Nuances of the female nurse-physician relationship: an evolution across time F St-Pierre, R Warsame Mayo Clinic Proceedings 95 (5), 1040-1049, 2020 | 6 | 2020 |
| CLO22-043: Humoral immune response following COVID-19 vaccination in patients with chronic lymphocytic leukemia and other indolent lymphomas: A large, single-center … PG Doukas, F St Pierre, J Boyer, M Nieves, S Ma Journal of the National Comprehensive Cancer Network 20 (3.5), CLO22-043 …, 2022 | 5 | 2022 |
| CLL-211 humoral immune response following COVID-19 vaccination in patients with Chronic Lymphocytic Leukemia (CLL) and Indolent Non-Hodgkin Lymphoma (NHL): results from a large … F St-Pierre, P Doukas, J Boyer, M Nieves, S Ma Clinical Lymphoma Myeloma and Leukemia 22, S273, 2022 | 4 | 2022 |
| Diagnosis of hypothenar hammer syndrome in a patient with acute ulnar artery occlusion F St-Pierre, RF Shepherd, MA Bartlett BMJ Case Reports CP 12 (9), e230963, 2019 | 4 | 2019 |
| Correlation between different levels of HER2 expression in circulating tumor cells (cHER2 ratio) and metastatic behavior in stageIVaggressive breast cancer. P D'Amico, C Reduzzi, S Gandini, L Gerratana, W Qiang, Q Zhang, ... Journal of Clinical Oncology 39 (15_suppl), 3036-3036, 2021 | 3 | 2021 |
| Impact of the COVID-19 pandemic on internal medicine training in the United States: results from a national survey F St-Pierre, R Petrosyan, A Gupta, S Hughes, J Trickett, S Read, ... BMC Health Services Research 23 (1), 1285, 2023 | 2 | 2023 |
| Phase I study of novel SYK inhibitor TAK‐659 (mivavotinib) in combination with R‐CHOP for front‐line treatment of high‐risk diffuse large B‐cell lymphoma R Karmali, F St‐Pierre, S Ma, KD Foster, J Kaplan, X Mi, B Pro, JN Winter, ... EJHaem 4 (1), 108-114, 2023 | 2 | 2023 |
| Bone involvement on PET/CT predicts event‐free survival in follicular lymphoma Grade 3B F St‐Pierre, SM Broski, BR LaPlant, K Ristow, WR Macon, TM Habermann, ... British journal of haematology 191 (2), e41-e43, 2020 | 2 | 2020 |
| A multicenter study analyzing survival and prognostic factors in patients with leukemic phase follicular lymphoma A Trabolsi, N Epperla, K Annunzio, DM Kaplan, P Doukas, F St-Pierre, ... Blood 142, 3770, 2023 | 1 | 2023 |
| Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study PG Doukas, F St. Pierre, R Karmali, X Mi, J Boyer, M Nieves, MG Ison, ... The oncologist 28 (10), e930-e941, 2023 | 1 | 2023 |
| Maximizing FDG-PET/CT utility in staging of follicular lymphoma (FL): the role of spleen involvement and bone standardized uptake values F St-Pierre, S Broski, B Laplant, TM Habermann, TE Witzig Blood 134, 2811, 2019 | 1 | 2019 |
